Targeting effector memory T cells with alefacept in new onset type 1 diabetes: 12 month results from the T1DAL study

Files in this item

This item appears in the following Collection(s)

Available in accordance with the Publisher Policy. Please refer to the publisher's site for terms of use.

Search Repository

My Account